The Trans Academic Cancer Genetics II
The Trans-Academic Cancer Genetics II (TACG II) and Oncology Update international symposium for genetics and cancer will take place in a beautiful city Yogyakarta, Indonesia. TACG forum consists of clinicians, geneticists, and academic professionals that are invited and elected to become active members of the forum. The symposium uses a multidisciplinary approach model consisting of scientists, clinicians, biologists, and researchers, where we all will share knowledge, skills, experiences and rencent data from their studies. The tremendeus advantages from this symposium are that we shall have a cutting-edge international and regional network for collaborative research and international publications. Recently, research in basic and translational cancer genetics and epigenetics grows rapidly. Building networks and collaboration both regional and international are very essential to develop better scientific outcome. Therefore, it is a perfect time for the meeting organizers to hold this inaugural symposium.
The proceedings of this symposium will be published as a supplement in Asia-Pacific Journal of Clinical Oncology and Asia Pacific Journal of Cancer Prevention including abstracts from international speakers, including Prof. Hanne Meijers-Heijboer, MD, PhD (Head of the Department of Clinical Genetics VU University Medical Center (VUMC) and Academisch Medisch Centrum (AMC) Amsterdam, The Netherlands), Gerard Pals, Prof-PhD (VU University Medical Centre, The Netherlands), Joanne Ngeow, MD.PhD (National Cancer Center Singapore, NUS-Duke),. Discussion will be focused on sharing experiences of setting up familial cancer clinic, genetic study and cancer research in Hongkong, Germany, Singapore, Australia, and the Netherlands as well as potential ground-breaking application in Indonesia.
Genetic diversity across Asia and particularly Indonesia might significanly influence intra- and inter-tumoral heterogeneity as well as immune responses against infections and cancers that will be discussed intensively during the symposium. This conference will also provide a unique opportunity to learn about and keep up to date with the rapidly progressing area of cancer genetics and genetic diseases and the clinical management. It will cover presentations from cancer genome projects, cancer genome atlas, genetic diseases in general, cancer functional genomics, and translation and clinical impact of scientific results from the recent human genetic and cancer genetic study.